JTC Employer Solutions Trustee’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$198K Sell
1,550
-83,195
-98% -$10.4M 0.02% 151
2025
Q4
$10.3M Buy
84,745
+83,195
+5,367% +$9.54M 0.7% 18
2025
Q3
$155K Hold
1,550
0.01% 172
2025
Q2
$128K Hold
1,550
0.01% 177
2025
Q1
$126K Hold
1,550
0.01% 180
2024
Q4
$139K Hold
1,550
0.01% 166
2024
Q3
$153K Hold
1,550
0.01% 158
2024
Q2
$144K Hold
1,550
0.01% 160
2024
Q1
$147K Hold
1,550
0.01% 165
2023
Q4
$141K Hold
1,550
0.01% 163
2023
Q3
$113K Hold
1,550
0.01% 181
2023
Q2
$129K Hold
1,550
0.01% 166
2023
Q1
$118K Hold
1,550
0.01% 180
2022
Q4
$128K Hold
1,550
0.01% 172
2022
Q3
$123K Buy
1,550
+750
+94% +$63.2K 0.02% 147
2022
Q2
$59K Buy
+800
New +$60.1K 0.01% 185

Other funds holding XBI

JTC Employer Solutions Trustee's XBI Position: Q1 2026 in Review

JTC Employer Solutions Trustee reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 98% in Q1 2026, selling an estimated $10.4M and leaving 1,550 shares worth $198K. The position accounts for 0.02% of the portfolio, ranked #151.

JTC Employer Solutions Trustee first reported a position in XBI in Q2 2022 and has held it in 16 quarters since. The position peaked at $10.3M in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • JTC Employer Solutions Trustee held 1,550 shares of State Street SPDR S&P Biotech ETF worth $198K as of Q1 2026.
  • JTC Employer Solutions Trustee sold 83,195 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $10.4M.
  • State Street SPDR S&P Biotech ETF made up 0.02% of JTC Employer Solutions Trustee's portfolio in Q1 2026, its #151 holding.
  • JTC Employer Solutions Trustee first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 16 quarters since.
  • JTC Employer Solutions Trustee's State Street SPDR S&P Biotech ETF position peaked at $10.3M in Q4 2025.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2026, filed 19 May 2026.